Overview of and Update on the Reorganization  : Endocrinology, Metabolism, Nutrition, and  Reproductive Sciences (EMNR) IR...
Center for Scientific Review    (C S R ) <ul><li>Receives, processes, and refers applications submitted to NIH and some ot...
C  S  R <ul><li>CSR reviews about 70 % of grant applications submitted to NIH </li></ul><ul><li>CSR reviews most investiga...
Beginnings of the Reorganization   <ul><li>In late 1996,  Dr. Ellie Ehrenfeld came to NIH and was soon led by discussions ...
Panel on Scientific Boundaries for Review (PSBR): Phase 1 <ul><li>Defined principles for organizing science into clusters ...
Input from Research Communities – Phase 1 <ul><li>PSBR presented its draft report to CSR in May 1999 </li></ul><ul><li>Dra...
Panel on  Scientific Boundaries for Review (PSBR) <ul><li>January 2000, </li></ul><ul><li>23 IRGs were outlined with the e...
Panel on Scientific Boundaries for Review: Phase 2 <ul><li>Design and establish study sections for each IRG </li></ul>
Guidelines for Phase 2 <ul><li>Seven IRGs (recently established) were exempt from reorganization ( Neuroscience, Behaviora...
Preparation for Phase 2 Mock Sort of Applications <ul><li>~10,000 applications from May 2000 Council round were sorted int...
Preparation for Phase 2  (cont’d.) <ul><li>A second mock sort was conducted using applications from the October  2002 Coun...
Process for  Implementing  Phase 2 <ul><li>For each proposed IRG, CSR Division Directors appointed Steering Committees com...
Process for  Implementing  Phase 2 (Cont’d) <ul><li>Proposed study sections were posted on the Web for broad community com...
Current Status for EMNR IRG <ul><li>SSB Team of the EMNR IRG met in April, 2002 </li></ul><ul><li>proposed 7 study section...
Study Section Boundary (SSB) Team of EMNR proposed  7 study sections <ul><li>Molecular and Cellular Endocrinology (MCE) </...
<ul><li>MEETING ROSTER  </li></ul><ul><li>CENTER FOR SCIENTIFIC REVIEW ADVISORY COMMITTEE  </li></ul><ul><li>Endocrinology...
<ul><li>LEIBEL, RUDOLPH L., MD  </li></ul><ul><li>PROFESSOR  </li></ul><ul><li>HEAD, DIVISION OF MOLECULAR GENETICS  </li>...
<ul><li>WEISS, GERSON, MD*   </li></ul><ul><li>PROFESSOR AND CHAIR  </li></ul><ul><li>DEPARTMENT OF OBSTETRICS, GYNECOLOGY...
Integrative and Clinical Endocrinology and reproduction (ICER) <ul><li>Physiology and pathophysiology of endocrine systems...
Cellular, Molecular and Integrative Reproduction (CMIR) <ul><li>Biology of germ cells and gametes, early events in concept...
Pregnancy and Neonatology (PN) <ul><li>All aspects of intrauterine mammalian development from implantation through pregnan...
Implementation Process <ul><li>Establishing the roster of review panels:  Invited current chartered members to select for ...
Implementation Process (cont’d.) <ul><li>Finalized the EMNR IRG Descriptions and Provisional Rosters </li></ul><ul><li>Des...
How to direct applications to appropriate study section  <ul><li>EMNR IRG study section descriptions (visit the CSR websit...
Ongoing and Future Efforts <ul><li>Outreach efforts will be intensified to show applicants how to benefit from changes at ...
Streamlining Initiatives <ul><li>Electronic Grant Application Submission   </li></ul><ul><li>Self-Referral by Investigator...
Learn More About CSR’s Reorganization   http://www.csr.nih.gov/review/reorgact.asp
Upcoming SlideShare
Loading in...5
×

Overview of and Update on the Reorganization :

524

Published on

Published in: Technology, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
524
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Overview of and Update on the Reorganization :

  1. 1. Overview of and Update on the Reorganization : Endocrinology, Metabolism, Nutrition, and Reproductive Sciences (EMNR) IRG Proposed by the Panel on Scientific Boundaries for Review Center for Scientific Review, N I H, U.S. Department of Health and Human Services
  2. 2. Center for Scientific Review (C S R ) <ul><li>Receives, processes, and refers applications submitted to NIH and some other DHHS agencies. </li></ul><ul><li>The primary goal is to see that NIH applications receive fair, independent, expert, and timely review--free from inappropriate influence— </li></ul><ul><li>so NIH can fund the most promising research. </li></ul>
  3. 3. C S R <ul><li>CSR reviews about 70 % of grant applications submitted to NIH </li></ul><ul><li>CSR reviews most investigator initiated, fellowship, SBIR/STTR applications sent to NIH from USA and foreign countries </li></ul><ul><li>(R01, R21, R15, F32, SBIR/STTR) </li></ul>
  4. 4. Beginnings of the Reorganization <ul><li>In late 1996, Dr. Ellie Ehrenfeld came to NIH and was soon led by discussions with scientists inside and outside of NIH to propose a systematic reorganization of CSR's study sections so they can better review the increasingly complex and diverse grant applications submitted to NIH. </li></ul>
  5. 5. Panel on Scientific Boundaries for Review (PSBR): Phase 1 <ul><li>Defined principles for organizing science into clusters of study sections called Integrated Review Groups (IRGs) </li></ul><ul><li>Recommended a set of 23 IRGs (EMNR IRG was one them) Developed process for establishing study sections </li></ul><ul><li>Recommended guidelines for “cultural” practices in study sections </li></ul>
  6. 6. Input from Research Communities – Phase 1 <ul><li>PSBR presented its draft report to CSR in May 1999 </li></ul><ul><li>Draft report was sent to professional societies – many of whom organized group responses </li></ul><ul><li>Draft report was also posted on the Web for individual comments (~750 received) </li></ul><ul><li>All comments were considered </li></ul><ul><li>Meetings and teleconferences were held with concerned communities </li></ul><ul><li>Draft report was revised </li></ul><ul><li>Report was finalized after it was accepted by the CSR Advisory Committee on January 10, 2000 </li></ul>
  7. 7. Panel on Scientific Boundaries for Review (PSBR) <ul><li>January 2000, </li></ul><ul><li>23 IRGs were outlined with the expectation that, as much as possible, new study sections would be designed to bring basic science studies closer to the organ or disease that they address </li></ul><ul><li>http://www.csr.nih.gov/Events/summary012000.htm </li></ul>
  8. 8. Panel on Scientific Boundaries for Review: Phase 2 <ul><li>Design and establish study sections for each IRG </li></ul>
  9. 9. Guidelines for Phase 2 <ul><li>Seven IRGs (recently established) were exempt from reorganization ( Neuroscience, Behavioral and social sciences, AIDS and related research) </li></ul><ul><li>Overlap is good </li></ul><ul><li>Though applications should, in general, be reviewed in IRGs focused on specific diseases or organ systems, there are cross-cutting themes that should be clustered together instead of being distributed across many IRGs </li></ul>
  10. 10. Preparation for Phase 2 Mock Sort of Applications <ul><li>~10,000 applications from May 2000 Council round were sorted into the proposed study sections </li></ul><ul><ul><li>Referral staff followed PSBR guidelines and identified ambiguities </li></ul></ul><ul><ul><li>Review staff reviewed the resulting sort and identified overlaps, errors, and disagreements </li></ul></ul><ul><li>A database was constructed to catalog issues and concerns </li></ul>
  11. 11. Preparation for Phase 2 (cont’d.) <ul><li>A second mock sort was conducted using applications from the October 2002 Council round to identify new trends and make appropriate course corrections </li></ul>
  12. 12. Process for Implementing Phase 2 <ul><li>For each proposed IRG, CSR Division Directors appointed Steering Committees composed of CSR review and Institute program staff to-- </li></ul><ul><ul><li>Identify all scientific communities involved in IRG </li></ul></ul><ul><ul><li>Contact relevant professional societies for nominations </li></ul></ul><ul><ul><li>Select and convene Study Section Boundaries (SSB) Teams of experts in field plus representative(s) from parent PSBR </li></ul></ul><ul><li>SSB Teams involving 384 external experts and 180 representatives from NIH Institutes and Centers drafted designs for 16 IRGs based on sorted applications and the comments database </li></ul>
  13. 13. Process for Implementing Phase 2 (Cont’d) <ul><li>Proposed study sections were posted on the Web for broad community comment (over 1,800 received) </li></ul><ul><li>Additional consultations and revisions were made </li></ul><ul><li>When overlaps occurred, CSR solicited input from relevant communities to make appropriate modifications and held final recommendations until all SSB Teams provide input </li></ul><ul><li>CSR Advisory Committee has reviewed all but two SSB Team proposals </li></ul><ul><li>Study Section boundaries will only be final once all SSB teams have completed their deliberations </li></ul><ul><li>CSR anticipates it will complete its reorganization in early 2005 </li></ul>
  14. 14. Current Status for EMNR IRG <ul><li>SSB Team of the EMNR IRG met in April, 2002 </li></ul><ul><li>proposed 7 study sections </li></ul><ul><li>CSR Advisory Committee has approved study section recommendations for EMNR IRG on May 12-13, 2003 </li></ul><ul><li>Implementation will be one year after study sections established by the CSR Director </li></ul><ul><li>First meetings of components study sections expected for June 2004 (receipt of Feb/March) </li></ul><ul><li>(We are right on schedule) </li></ul>
  15. 15. Study Section Boundary (SSB) Team of EMNR proposed 7 study sections <ul><li>Molecular and Cellular Endocrinology (MCE) </li></ul><ul><li>Integrative and Clinical Endocrinology and reproduction (ICER) </li></ul><ul><li>Cellular, Molecular and Integrative Reproduction (CMIR) </li></ul><ul><li>Pregnancy and Neonatology (PN) </li></ul><ul><li>Cellular Aspects of Diabetes and Obesity (CADO) </li></ul><ul><li>Integrative Physiology of Obesity and Diabetes (IPOD) </li></ul><ul><li>Integrative Nutrition and Metabolic Processes (INMP) </li></ul>
  16. 16. <ul><li>MEETING ROSTER </li></ul><ul><li>CENTER FOR SCIENTIFIC REVIEW ADVISORY COMMITTEE </li></ul><ul><li>Endocrinology, Metabolism, Nutrition & Reproductive Sciences Study Section Boundaries Team </li></ul><ul><li>APRIL 28 - 30, 2002 </li></ul><ul><li>CHAIRPERSON </li></ul><ul><li>LORIAUX, LYNN D., MD, PHD </li></ul><ul><li>PROFESSOR AND CHAIRMAN </li></ul><ul><li>DEPARTMENT OF MEDICINE </li></ul><ul><li>OREGON HEALTH SCIENCES UNIVERSITY </li></ul><ul><li>PORTLAND, OR 97201 </li></ul><ul><li>MEMBERS </li></ul><ul><li>BIGGERS, JOHN D., DSC, PHD </li></ul><ul><li>PROFESSOR OF CELL BIOLOGY </li></ul><ul><li>DEPARTMENT OF CELL BIOLOGY </li></ul><ul><li>HARVARD MEDICAL SCHOOL </li></ul><ul><li>BOSTON, MA 02115 </li></ul><ul><li>BROWNLEE, MICHAEL A., MD </li></ul><ul><li>ANITA & JACK SALTZ PROFESSOR OF DIABETES </li></ul><ul><li>RESEARCH </li></ul><ul><li>DEPARTMENT OF MEDICINE & PATHOLOGY </li></ul><ul><li>ALBERT EINSTEIN COLLEGE OF MEDICINE </li></ul><ul><li>BRONX, NY 10461 </li></ul><ul><li>CHAIT, ALAN, MD </li></ul><ul><li>EDWIN L. BIERMAN PROFESSOR OF MEDICINE </li></ul><ul><li>HEAD, DIVISION OF METABOLISM, </li></ul><ul><li>ENDCRIONOLOGY </li></ul><ul><li>& NUTRITION </li></ul><ul><li>DEPARTMENT OF MEDICINE </li></ul><ul><li>UNIVERSITY OF WASHINGTON </li></ul><ul><li>SEATTLE, WA 98195 </li></ul><ul><li>CHIN, WILLIAM W., MD </li></ul><ul><li>VICE PRESIDENT, GENE REGULATION, BONE </li></ul><ul><li>& INFLAMMATION </li></ul><ul><li>RESEARCH, CLINICAL INVESTIGATION AND </li></ul><ul><li>PLATFORM BIOLOGY </li></ul><ul><li>LILLY RESEARCH LABORATORIES </li></ul><ul><li>LILLY CORPORATE CENTER </li></ul><ul><li>INDIANAPOLIS, IN 46285 </li></ul><ul><li>COUSINS, ROBERT J., PHD </li></ul><ul><li>BOSTON FAMILY PROFESSOR OF HUMAN NUTRITION </li></ul><ul><li>DIRECTOR, CENTER FOR NUTRITIONAL SCIENCES </li></ul><ul><li>FOOD SCIENCE & HUMAN NUTRITION DEPARTMENT </li></ul><ul><li>UNIVERSITY OF FLORIDA </li></ul><ul><li>GAINESVILLE, FL 32611 </li></ul><ul><li>HILL, JAMES O., PHD </li></ul><ul><li>PROFESSOR </li></ul><ul><li>DEPARTMENT OF PEDIATRICS </li></ul><ul><li>DIRECTOR, CLINICAL NUTRITION RESEARCH </li></ul><ul><li>CENTER FOR HUMAN NUTRITION </li></ul><ul><li>UNIVERSITY OF COLORADO HEALTH SCIENCES </li></ul><ul><li>CENTER </li></ul><ul><li>DENVER, CO 80262 </li></ul><ul><li>KAHN, BARBARA B., MD </li></ul><ul><li>CHIEF, DIVISION OF ENDOCRINOLOGY, </li></ul><ul><li>DIABETES & METABOLISM </li></ul><ul><li>BETH ISRAEL DEACONESS MEDICAL CENTER </li></ul><ul><li>PROFESSOR OF MEDICINE </li></ul><ul><li>HARVARD MEDICAL SCHOOL </li></ul><ul><li>BOSTON, MA 02215 </li></ul><ul><li>KING, JANET C., PHD </li></ul><ul><li>DIRECTOR AND PROFESSOR OF NUTRITION </li></ul><ul><li>WESTERN HUMAN NUTRITION RESEARCH CENTER </li></ul><ul><li>UNIVERSITY OF CALIFORNIA </li></ul><ul><li>DAVIS, CA 95616 </li></ul>
  17. 17. <ul><li>LEIBEL, RUDOLPH L., MD </li></ul><ul><li>PROFESSOR </li></ul><ul><li>HEAD, DIVISION OF MOLECULAR GENETICS </li></ul><ul><li>COLUMBIA UNIVERSITY COLLEGE OF </li></ul><ul><li>PHYSICIANS & SURGEONS </li></ul><ul><li>NEW YORK, NY 10032 </li></ul><ul><li>MEANS, ANTHONY R., PHD </li></ul><ul><li>NANALINE H. DUKE PROFESSOR & CHAIRMAN </li></ul><ul><li>DEPARTMENT OF PHARMACOLOGY & CANCER BIOLOGY </li></ul><ul><li>DUKE UNIVERSITY MEDICAL CENTER </li></ul><ul><li>DURHAM, NC 27710 </li></ul><ul><li>NILSON, JOHN H., PHD </li></ul><ul><li>JOHN H. HORD PROFESSOR AND CHAIR </li></ul><ul><li>DEPARTMENT OF PHARMACOLOGY </li></ul><ul><li>SCHOOL OF MEDICINE </li></ul><ul><li>CASE WESTERN RESERVE UNIVERSITY </li></ul><ul><li>CLEVELAND, OH 44106 </li></ul><ul><li>PHILLIPPE, MARK, MD* </li></ul><ul><li>PROFESSOR AND CHAIRMAN </li></ul><ul><li>DEPARTMENT OFOBSTETRICS & GYNECOLOGY </li></ul><ul><li>UNIVERSITY OF VERMONT </li></ul><ul><li>COLLEGE OF MEDICINE </li></ul><ul><li>BURLINGTON, VT 05401 </li></ul><ul><li>RICHARDS, JOANNE S., PHD * </li></ul><ul><li>PROFESSOR </li></ul><ul><li>DEPARTMENT OF MOLECULAR & CELLULAR </li></ul><ul><li>BIOLOGY </li></ul><ul><li>BAYLOR COLLEGE OF MEDICINE </li></ul><ul><li>HOUSTON, TX 77030 </li></ul><ul><li>RIZZA, ROBERT A., MD </li></ul><ul><li>PROFESSOR OF MEDICINE </li></ul><ul><li>CHAIR, DIVISION OF ENDOCRINOLOGY, </li></ul><ul><li>DIABETES, METABOLISM & NUTRITION </li></ul><ul><li>MAYO CLINIC </li></ul><ul><li>ROCHESTER, MN 55905 </li></ul><ul><li>SEMENKOVICH, CLAY F., MD </li></ul><ul><li>PROFESSOR OF MEDICINE & CELL BIOLOGY & </li></ul><ul><li>PHYSIOLOGY </li></ul><ul><li>DEPARTMENT OF INTERNAL MEDICINE </li></ul><ul><li>WASHINGTON UNIVERSITY IN ST. LOUIS </li></ul><ul><li>ST. LOUIS, MO 63110 </li></ul><ul><li>STEINER, DONALD F., MD </li></ul><ul><li>PROFESSOR & SENIOR INVESTIGATOR </li></ul><ul><li>DEPARTMENT OF BIOHEMISTRY & </li></ul><ul><li>MOLECULAR BIOLOGY </li></ul><ul><li>UNIVERSITY OF CHICAGO </li></ul><ul><li>CHICAGO, IL 60637 </li></ul><ul><li>STRAUSS, JEROME F. III, MD, PHD ** </li></ul><ul><li>LUIGI MASTROIANNI JR. PROFESSOR </li></ul><ul><li>DIRECTOR, CENTER FOR RESEARCH ON </li></ul><ul><li>REPRODUCTIVES & WOMEN'S HEALTH </li></ul><ul><li>ASSOCIATE CHAIRMAN </li></ul><ul><li>DEPARTMENT OF OBSTETRICS AND GYNECOLOGY </li></ul><ul><li>UNIVERSITY OF PENNSYLVANIA </li></ul><ul><li>PHILADELPHIA, PA 19104 </li></ul><ul><li>TALAMANTES, FRANK J. JR, PHD </li></ul><ul><li>VICE PROVOST AND DEAN OF THE GRADUATE DIVISION </li></ul><ul><li>PROFESSOR OF ENDOCRINOLOGY </li></ul><ul><li>UNIVERSITY OF CALIFORNIA </li></ul><ul><li>SANTA CRUZ, CA 95064 </li></ul><ul><li>VALE, WYLIE W. JR., PHD* </li></ul><ul><li>PROFESSOR AND HEAD </li></ul><ul><li>PEPTIDE BIOLOGY LABORATORIES </li></ul><ul><li>THE SALK INSTITUTE </li></ul><ul><li>LA JOLLA, CA 92037 </li></ul>
  18. 18. <ul><li>WEISS, GERSON, MD* </li></ul><ul><li>PROFESSOR AND CHAIR </li></ul><ul><li>DEPARTMENT OF OBSTETRICS, GYNECOLOGY </li></ul><ul><li>& WOMEN'S HEALTH </li></ul><ul><li>UMD-NEW JERSEY MEDICAL SCHOOL </li></ul><ul><li>NEWARK, NJ 07103 </li></ul><ul><li>WHITE, MORRIS F., PHD </li></ul><ul><li>SENIOR INVESTIGATOR </li></ul><ul><li>JOSLIN DIABETES CENTER </li></ul><ul><li>HOWARD HUGHES MEDICAL INSTITUTE </li></ul><ul><li>BOSTON, MA 02215 </li></ul><ul><li>WISE, PHYLLIS M., PHD </li></ul><ul><li>PROFESSOR OF NEUROBIOLOGY, PHYSIOLOGY </li></ul><ul><li>& BEHAVIOR </li></ul><ul><li>DEAN OF BIOLOGICAL SCIENCES </li></ul><ul><li>UNIVERSITY OF CALIFORNIA DAVIS </li></ul><ul><li>DAVIS, CA 95616-8536 </li></ul><ul><li>ZIRKIN, BARRY R., PHD* </li></ul><ul><li>PROFESSOR </li></ul><ul><li>DEPARTMENT OF BIOCHEMISTRY & MOLECULAR BIOLOGY </li></ul><ul><li>DIVISION OF REPRODUCTIVE BIOLOGY </li></ul><ul><li>SCHOOL OF PUBLIC HEALTH </li></ul><ul><li>JOHNS HOPKINS UNIVERSITY </li></ul><ul><li>BALTIMORE, MD 21205 </li></ul><ul><li>DESIGNATED FEDERAL OFFICIAL </li></ul><ul><li>MARTIN, MICHAEL, PHD </li></ul><ul><li>DIRECTOR </li></ul><ul><li>DIVISION OF PHYSIOLOGICAL SYSTEMS </li></ul><ul><li>CENTER FOR SCIENTIFIC REVIEW </li></ul><ul><li>BETHESDA, MD 20892 </li></ul><ul><li>PROGRAM REPRESENTATIVES </li></ul><ul><li>BELLINO, FRANCIS, PHD </li></ul><ul><li>BIOLOGY OF AGING PROGRAM </li></ul><ul><li>NATIONAL INSTITUTE ON AGING , NIH </li></ul><ul><li>BETHESDA, MD 20892 </li></ul><ul><li>DEPAOLO, LOUIS V., PHD </li></ul><ul><li>DIRECTOR, REPRODUCTIVE NEUROENDOCRINOLOGY </li></ul><ul><li>PROGRAM </li></ul><ul><li>REPRODUCTIVE SCIENCES BRANCH </li></ul><ul><li>NICHD, NIH </li></ul><ul><li>BETHESDA, MD 20892 </li></ul><ul><li>FREEMAN, COLETTE S. PHD </li></ul><ul><li>CHIEF, CANCER CELL BIOLOGY RESEARCH </li></ul><ul><li>DIVISION OF CANCER BIOLOGY </li></ul><ul><li>NCI, NIH </li></ul><ul><li>BETHESDA, MD 20892 </li></ul><ul><li>HEINDEL, JERROLD J., PHD </li></ul><ul><li>DIVISION OF EXTRAMURAL RESEARCH & </li></ul><ul><li>TRAINING </li></ul><ul><li>NIEHS, NIH </li></ul><ul><li>RESEARCH TRIANGLE PARK, NC 27709 </li></ul><ul><li>MARGOLIS, RONALD N., PHD </li></ul><ul><li>SENIOR ADVISOR FOR MOLECULAR ENDOCRINOLOGY </li></ul><ul><li>DIVISION OF DIABETES, ENDOCRINOLOGY </li></ul><ul><li>& KIDNEY DISEASES </li></ul><ul><li>NIDDK, NIH </li></ul><ul><li>BETHESDA, MD 20892 </li></ul><ul><li>OTHER REVIEW STAFF </li></ul><ul><li>KNECHT, MICHAEL, PHD </li></ul><ul><li>SCIENTIFIC REVIEW ADMINISTRATOR </li></ul><ul><li>CENTER FOR SCIENTIFIC REVIEW </li></ul><ul><li>NIH </li></ul><ul><li>BETHESDA, MD </li></ul>
  19. 19. Integrative and Clinical Endocrinology and reproduction (ICER) <ul><li>Physiology and pathophysiology of endocrine systems, and clinical endocrine and reproductive science investigations (Novel hormone based therapies); </li></ul><ul><li>Adaptation and response to environmental stress and homeostatic challenge, including endocrine disruptors and xenobiotics; </li></ul><ul><li>Genetics and genomics, growth, development, and aging; </li></ul><ul><li>Neuroendocrinology, neuroendocrine control of reproductive processes; </li></ul><ul><li>Interactions with the cardiovascular, GI and immune systems, comparative edocrinology </li></ul>
  20. 20. Cellular, Molecular and Integrative Reproduction (CMIR) <ul><li>Biology of germ cells and gametes, early events in conception, and embryo development (including embryonic stem cells until the stage of implantation); </li></ul><ul><li>Reproductive toxicology; gonadal function; puberty; male and female reproductive aging; </li></ul><ul><li>Male and female reproductive tracts and their disorders; </li></ul><ul><li>Research on infertility, conception, gynecology and adrology </li></ul><ul><li>Molecular, cellular, systems and integrative aspects of reproductive biology </li></ul>
  21. 21. Pregnancy and Neonatology (PN) <ul><li>All aspects of intrauterine mammalian development from implantation through pregnancy, parturition and the neonatal period. </li></ul><ul><li>Normal physiology of pregnancy, parturition and postpartum period, disorders of pregnancy, neonatal development and diseases of the newborn. </li></ul><ul><li>Immunology of pregnancy, maternal nutrition, the effects of pharmaceuticals, xenobiotic agents, and environmental toxicants on pregnancy; </li></ul><ul><li>Placental endocrinology and function; </li></ul><ul><li>Clinical and basic genetics, molecular biology, cellular and organ physiology, and integrative biology. </li></ul>
  22. 22. Implementation Process <ul><li>Establishing the roster of review panels: Invited current chartered members to select for service in the new EMNR IRG study sections or other IRGs </li></ul><ul><li>Resolution of shared interest issues </li></ul>
  23. 23. Implementation Process (cont’d.) <ul><li>Finalized the EMNR IRG Descriptions and Provisional Rosters </li></ul><ul><li>Description and Provisional Rosters were posted on the CSR Web on 12/23/2003 </li></ul><ul><li>Description: www.csr.nih.gov/irgdesc.htm </li></ul><ul><li>Rosters: ww.csr.nih.gov/Roster_proto/sectionsl.asp </li></ul>
  24. 24. How to direct applications to appropriate study section <ul><li>EMNR IRG study section descriptions (visit the CSR website) </li></ul><ul><li>Provisional Rosters of study sections (website) </li></ul><ul><li>SRAs or and Institute program staff </li></ul><ul><li>Cover letter (indicate the content area of the application and suggest several possible study sections </li></ul>
  25. 25. Ongoing and Future Efforts <ul><li>Outreach efforts will be intensified to show applicants how to benefit from changes at CSR </li></ul><ul><li>Multiple assessments will be made to see how well the new organization functions. </li></ul><ul><li>Contacts with the professional societies and members of the scientific community will be maintained so CSR can benefit from their input </li></ul><ul><li>CSR will continue its ongoing initiative to conduct Working Group evaluations of each IRG every 5 years </li></ul>
  26. 26. Streamlining Initiatives <ul><li>Electronic Grant Application Submission </li></ul><ul><li>Self-Referral by Investigator </li></ul><ul><li>Shorten Time from Submission to Award </li></ul><ul><li>Shorten Re-Submission Time for Revised Applications </li></ul>
  27. 27. Learn More About CSR’s Reorganization http://www.csr.nih.gov/review/reorgact.asp
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×